JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$7.56B |
| 2 |
Micron Technology
MU
|
+$7.54B |
| 3 |
Advanced Micro Devices
AMD
|
+$6.58B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$6.44B |
| 5 |
Corning
GLW
|
+$4.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$3.25B |
| 2 |
ExxonMobil
XOM
|
+$3.16B |
| 3 |
Intuit
INTU
|
+$2.89B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$2.25B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.59% |
| 2 | Miscellaneous | 24.07% |
| 3 | Financials | 7.91% |
| 4 | Communication Services | 7.54% |
| 5 | Industrials | 7.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3326
4D Molecular Therapeutics
FDMT
$766M
| $5.18M | ﹤0.01% |
402,137
-13,518
| -3% | -$132K |
|
|
PPLC
3327
PPL Corp Corporate Units
PPLC
| $5.17M | ﹤0.01% |
100,721
+11,200
| +13% | +$554K |
|
3328
Array Technologies
ARRY
$653M
| $5.16M | ﹤0.01% |
712,794
+220,474
| +45% | +$1.76M |
|
3329
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.3B
| $5.16M | ﹤0.01% |
226,820
-592,266
| -72% | -$13.4M |
|
3330
Taysha Gene Therapies
TSHA
$1.64B
| $5.16M | ﹤0.01% |
766,282
+11,500
| +2% | +$68.1K |
|
3331
Evolv Technologies
EVLV
$900M
| $5.16M | ﹤0.01% |
918,981
+838,098
| +1,036% | +$5.25M |
|
3332
CALL
Medtronic
MDT
$120B
| $5.16M | ﹤0.01% |
63,700
+8,700
| +16% | +$702K |
|
3333
Crane NXT
CXT
$2.75B
| $5.15M | ﹤0.01% |
102,389
-19,760
| -16% | -$843K |
|
|
SNXX
3334
Tradr 2X Long SNDK Daily ETF
SNXX
$2.18B
| $5.13M | ﹤0.01% |
147,565
+107,565
| +269% | +$2.29M |
|
|
BLTE
3335
Belite Bio
BLTE
$6.83B
| $5.13M | ﹤0.01% |
33,181
+33,178
| +1,105,933% | +$5.09M |
|
3336
Cheesecake Factory
CAKE
$4.86B
| $5.13M | ﹤0.01% |
62,482
-3,851
| -6% | -$249K |
|
3337
Atlanta Braves Holdings Series A
BATRA
$3.63B
| $5.13M | ﹤0.01% |
90,342
-1,398
| -2% | -$74.5K |
|
3338
Syndax Pharmaceuticals
SNDX
$1.58B
| $5.13M | ﹤0.01% |
231,446
-27,073
| -10% | -$563K |
|
3339
QuantumScape Corp
QS
$3.06B
| $5.13M | ﹤0.01% |
652,738
+53,583
| +9% | +$402K |
|
3340
Northwest Natural Holdings
NWN
$2.05B
| $5.13M | ﹤0.01% |
100,586
-25,420
| -20% | -$1.3M |
|
3341
BioCryst Pharmaceuticals
BCRX
$2.13B
| $5.12M | ﹤0.01% |
525,449
-1,016,529
| -66% | -$9.19M |
|
3342
iShares S&P 500 BuyWrite ETF
IVVW
$346M
| $5.11M | ﹤0.01% |
115,289
+11,385
| +11% | +$504K |
|
3343
iShares MSCI Intl Momentum Factor ETF
IMTM
$4.27B
| $5.11M | ﹤0.01% |
96,834
-29,517
| -23% | -$1.54M |
|
3344
CALL
PepsiCo
PEP
$184B
| $5.1M | ﹤0.01% |
36,800
-18,600
| -34% | -$2.78M |
|
3345
PUT
Neurocrine Biosciences
NBIX
$15.3B
| $5.1M | ﹤0.01% |
30,000
-51,000
| -63% | -$7.57M |
|
3346
Celcuity
CELC
$4.08B
| $5.1M | ﹤0.01% |
48,719
-5,147
| -10% | -$594K |
|
3347
Manitowoc
MTW
$745M
| $5.09M | ﹤0.01% |
359,725
-36,446
| -9% | -$463K |
|
3348
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.17B
| $5.09M | ﹤0.01% |
173,851
-13,752
| -7% | -$400K |
|
|
GPGI
3349
GPGI Inc
GPGI
$3.5B
| $5.08M | ﹤0.01% |
318,571
-26,918
| -8% | -$385K |
|
3350
Precigen
PGEN
$2.65B
| $5.08M | ﹤0.01% |
849,298
-23,985
| -3% | -$104K |
|
Similar funds
JP Morgan Chase's Q2 2026 Portfolio in Review
As of Q2 2026, JP Morgan Chase held 8,251 positions worth $1.81T, up 16% from $1.56T the previous quarter. Its ten largest holdings account for 25% of the portfolio.
JP Morgan Chase's Q2 2026 filing shows 775 new, 3,152 increased, 2,890 reduced and 552 closed positions. Its largest new stake was SpaceX: 15,563,576 shares worth $2.56B. The largest sale was Walmart Inc, an estimated $3.25B.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Financials.
- JP Morgan Chase's largest Q2 2026 buy was SpaceX: 15,563,576 shares worth $2.56B.
- JP Morgan Chase added most to Alphabet (Google) Class A in Q2 2026, an estimated $7.56B increase.
- JP Morgan Chase's biggest Q2 2026 reduction was Walmart Inc, cutting an estimated $3.25B.
- JP Morgan Chase fully exited Coterra Energy in Q2 2026, selling an estimated $462M.
- JP Morgan Chase's ten largest holdings make up 25% of its $1.81T portfolio in Q2 2026.
- JP Morgan Chase opened 775 new positions and closed 552 in Q2 2026.
- JP Morgan Chase's portfolio value rose 16% quarter-over-quarter to $1.81T.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.